NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
8-K - NEKTAR THERAPEUTICS - 7.01
Filed:
2026-04-20
AccNo:
0001193125-26-164186
Size:
131 KB
Item 7.01: Regulation FD Disclosure
发布时间04/20 20:58 UTC
首次发现04/20 21:00 UTC
热度105.4
重要度64
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 754 字符
Form 8-K - Current report: SEC Accession No. 0001193125-26-164186
Filing Date: 2026-04-20
Accepted: 2026-04-20 16:58:59
Documents: 11
Period of Report: 2026-04-20
Items: Item 7.01: Regulation FD Disclosure
NEKTAR THERAPEUTICS (Filer) CIK : 0000906709 (see all company filings) EIN. : 943134940 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 26875770 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | d136533d8k.htm iXBRL | 8-K
2 | XBRL TAXONOMY EXTENSION SCHEMA | nktr-20260420.xsd | EX-101.SCH
3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nktr-20260420_lab.xml | EX-101.LAB
4 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nktr-20260420_pre.xml | EX-101.PRE